2018 Top 5 Triptorelin Acetate Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

0
48

Triptorelin Acetate is a peptide formulation for injection that was initially developed and continues to be used mainly in the treatment of advanced metastatic prostate cancer. Additional indications developed subsequently include the treatment of uterine fibroids (a benign tumour of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilisation).
The global production of triptorelin acetate is about 2770 k units in 2015, the production region is mainly concentrated in Europe, the biggest three countries are France, Germany and Ireland. The top two companies are Ipsen and Ferring, they occupies about 95% market shares;
Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption Europe is about 38%, the North America consumes about 12% market share, China occupies about 9% market share, Japan occupies about 8.29% market share.
The production and consumption region is different, the production region is mainly concentrated in Europe, the consumption region is dispersion in all over the world; the countries which do not include in the Europe mainly depends on import.
Over the next five years, LPI(LP Information) projects that Triptorelin Acetate will register a 4.7% CAGR in terms of revenue, reach US$ 600 million by 2023, from US$ 460 million in 2017.

This report studies the global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:
Ipsen
Ferring
Chengdu Tiantaishan
TECNOFARMA
Changchun Gensci

 

Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 (forecast), like
North America (United States, Canada and Mexico)
Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
Europe (Germany, UK, France, Italy and Russia etc.)
South America (Brazil, Chile, Peru and Argentina)
Middle East and Africa (Egypt, South Africa, Saudi Arabia)

 

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
0.1 mg
3 mg
11.25 mg
Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into
Male Disease
Female Disease

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here